Advertisement

Topics

Speedy US review for MSD’s Keytruda in cervical cancer

05:35 EDT 14 Mar 2018 | PharmaTimes

US regulators will undertake a priority review of MSD’s Keytruda as a treatment for patients with advanced cervical cancer.

Original Article: Speedy US review for MSD’s Keytruda in cervical cancer

NEXT ARTICLE

More From BioPortfolio on "Speedy US review for MSD’s Keytruda in cervical cancer"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topic

Cervical Cancer
Cervical cancer is a malignant neoplasm of the cervix uteri or cervical area. Symptoms include vaginal bleeding, but may not present until later stages of the cancer. Cervical cancer can be treated using surgery (including local excision) in early stages...